Analyst Ratings for X4 Pharmaceuticals (XFOR)
XFOR Rating Summary
XFOR Price Target Summary
- Highest: $10.00 (Stifel)
- Lowest: $5.00 (H.C. Wainwright)
- Average: $7.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$7.50 (+99.5%)
* Over Last 12-Mos
Rating Score: 9.1 / 10
Percentile Rank: 90%
Avg. $ Target:
$7.50 (+99.5%)
* Over Last 12-Mos
Rating Score: 9.1 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/5/2025 | Stifel | James Condulis | New Coverage | Buy (N/A) |
10.00 (7.50) |
3.25 (3.76) |
15.69% | Details |
| 12/12/2023 | B.Riley » Updated 11/18/2024 |
Kalpit Patel | Downgrade | Neutral (Buy) |
0.50 (1.00) |
0.61 (3.76) |
516.39% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
